Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$24,434,770
+$123,344 QoQ
Shares Held
67,477
-2.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#342
of 3,139 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. AMGN ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
This page
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,434,770 | 67,477 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $24,311,426 | 69,096 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $22,738,225 | 69,470 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $21,411,642 | 75,874 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,456,170 | 76,846 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,134,928 | 67,838 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $18,463,997 | 70,841 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,812,145 | 70,799 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,820,722 | 73,038 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $21,848,001 | 76,843 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $22,408,243 | 77,801 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,429,578 | 79,735 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,620,794 | 88,374 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $20,160,982 | 83,396 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $27,040,625 | 102,957 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $24,659,210 | 109,402 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $27,204,102 | 111,813 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $25,095,837 | 103,779 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $23,764,705 | 105,635 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $21,469,143 | 100,960 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $26,134,753 | 105,039 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $27,006,862 | 117,462 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $30,194,207 | 118,800 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $30,108,472 | 127,654 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $24,156,901 | 119,158 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||